Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Gataparsen (development code LY2181308) is an antisense oligonucleotide that complementarily binds to survivin mRNA and inhibits its expression in tumor tissue. Gataparsen is being investigated for a number of different cancers. It is targeted at survivin which prevents cells dying.